Acute ultrastructural effects of MPTP on the nigrostriatal pathway of the C57BL/6 adult mouse: Evidence of compensatory plasticity in nigrostriatal neurons

Journal of Neuroscience Research

Volumn 59, Issue 1, 2000, Pages 126-135

  Cochiolo, Jeffrey A ^a   Ehsanian, Reza ^a   Bruck, David K ^a  

^a SAN JOSE STATE UNIVERSITY   (United States)

Author keywords

Dopaminergic; Electron microscopy; Parkinson's disease; Parkinsonism; Striatum; Substantia nigra

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; ELECTRON MICROSCOPY; MALE; MOUSE; NERVE CELL DEGENERATION; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

ANIMALS; DOPAMINE; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; NEOSTRIATUM; NEURONAL PLASTICITY; NEURONS; SUBSTANTIA NIGRA;

EID: 0033959255     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(20000101)59:1<126::AID-JNR15>3.0.CO;2-L     Document Type: Article

References (53)

1. Arai N, Misugi K, Goshima Y, Misu Y. 1990. Evaluation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism. Brain Res 515:37-63.
2. Ballard PA, Tetrud JW, Langston JW. 1985. Permanent parkinsonism in humans due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology 35:949-956.
3. Burns RS, Chineh CC, Markey SP, Ebert MH, Jacobowitz DM, Kopin IJ. 1983. A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci USA 80:4546-4550.
4. Carlin RK, Siekevitz P. 1983. Plasticity in the central nervous system: do synapses divide? Proc Natl Acad Sci USA 80:3517-3521.
5. Davis GC, Williams AC, Markey SP. 1979. Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res 1:249-254.
6. +) cause rapid ATP depletion in isolated hepatocytes. Biochem Biophys Res Commun 137:310-315.
7. Forno LS, Langston JW, DeLanney LE, Irwin I, Ricaurte GA. 1986. Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol 20:449-455.
8. Gupta M, Gupta BK, Thomas R, Bruemmer V, Sladek JR Jr, Felton DL. 1986. Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults. Neurosci Lett 70:326-331.
9. Hallman H, Olson L, Jonsson G. 1984. Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse. Eur J Pharmacol 97:133-136.
10. Hallman H, Lange J, Olson L, Strömberg I, Jonsson G. 1985. Neurochemical and histological characterization of neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on brain catecholamine neurons in the mouse. J Neurochem 44:117-127.
11. Heikkila RE, Hess A, Duvoisin RC. 1984a. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Science 224: 1451-1453.
12. Heikkila RE, Cabbat FS, Manzino L, Duvoisin RC. 1984b. Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311:467-469.
13. Ho A, Blum M. 1998. Induction of interleukin-1 associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J Neurosci 18:5614-5629.
14. Hornykiewicz O. 1993. Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv Neurol 60:140-147.
15. Ingham CA, Hood SH, Arbuthnott GW. 1989. Spine density on neostriatal neurones changes with 6-hydroxydopamine lesions and with age. Brain Res 503:334-338.
16. Ingham CA, Hood SH, Taggart P, Arbuthnott GW. 1998. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 18:4732-1743.
17. + concentrations and neurotoxicity. Life Sci 40:731-740.
18. Irwin I, Finnegan KT, DeLanney LE, DiMonte D, Langston JW. 1992. The relationship between aging, monomine oxidase, striatal dopamine, and the effects of MPTP in C57BL/6 mice: a critical reassessment. Brain Res 572:224-231.
19. Kaakkola S, Teravainen H. 1990. Animal models of parkinsonism. Pharmacol Toxicol 67:95-100.
20. Kerns JM, Sierens DK, Kao LC, Klawans H-L, Carvey PM. 1992. Synaptic plasticity in the rat striatum following chronic haloperidol treatment. Clin Neuropharmacol 15:488-500.
21. Kitt DA, Cork LC, Eidelberg F, Joh TH, Price DL. 1986. Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: a tyrosine hydroxylase immunocytochemical study in monkey. Neuroscience 4:1089-1103.
22. Langston JW, Ballard PA, Tetrud JW, Irwin I. 1983. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219:979-980.
23. Langston JW, Forno LS, Rebert CS, Irwin I. 1984. Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res 292:390-394.
24. Leonard S, Luthman D, Logel J, Luthman J, Antle C, Freedman R, Hoffer B. 1993. Acidic and basic fibroblast growth factor mRNAs are increased in striatum following MPTP-induced dopamine neurofiber lesion: assay by quantitative PCR. Molec Brain Res 18:275-284.
25. Linder JC, Klemfuss H, Groves PM. 1987. Acute ultrastructural and behavioral effects of MPTP in mice. Neurosci Lett 82:221-226.
26. Linder JC, Young SJ, Groves PM. 1995. Electron microscopic evidence for neurotoxicity in the basal ganglia. Neurochem Int 26:195-202.
27. Lnenicka GA, Hong SJ, Combatti M, LePage S. 1991. Activity-dependent development of synaptic varicosities at crayfish motor terminals. J Neurosci 11:1040-1048.
28. Markham CH, Diamond SG. 1993. Clinical overview of Parkinson's disease. Clin Neurosci 1:5-11.
29. Mizukawa K, Sora YH, Ogawa N. 1990. Ultrastructural changes of the substantia nigra, ventral tegmental area and striatum in MPTP-treated mice. Res Comm Chem Pathol Pharmacol 67:307-320.
30. Mitsumoto Y, Watanabe A, Mori A, Koga N. 1998. Spontaneous regeneration of nigostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice. Biochem Biophys Res Comm 248:660-663.
31. +, a metabolite of the neurotoxin MPTP. Life Sci 36:2503-2508.
32. Pickel VM, Chan J. 1995. Use of quantitative ultrastructural immunoperoxidase labeling for analysis of catecholamine neurotoxicity and plasticity. Neurochem Int 26:125-134.
33. Pickel VM, Johnson E, Carson M, Chan J. 1992. Ultrastructure of spared dopamine terminals in caudate-putamen nuclei of adult rats neonatally treated with intranigral 6-hydroxydopamine. Dev Brain Res 70:75-86.
34. Pierce JP, Lewin GR. 1994. An ultrastructural size principle. Neuroscience 58:441-446.
35. -) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase. J Neurochem 56:1184-1190.
36. Ramsay RR, Singer TP. 1986. Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by mitochondria. J Biol Chem 261:7585-7587.
37. +. Neurosci Lett 75:323-328.
38. Rapisardi SC, Warrington VOP, Wilson JS. 1990. Effects of MPTP on the fine structure of neurons in substantia nigra of dogs. Brain Res 512:147-154.
39. Reinhard JF Jr., Chao JY, Nichol CA. 1985. Catecholamine, serotonin and tetrahydrobiopterin levels in brain regions of male C57B1/6J mice treated with MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). In: Boulton AA, Maitre L, Bieck PR, Reiderer P, editors. Neuropsychopharmacology of trace amines. Clifton, NJ: Hamana Press, p. 279-284.
40. Reinhard JF Jr, Miller DB, O'Callaghan JP. 1988. The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: evidence for glial response to injury. Neurosci Lett 95:246-351.
41. Ricaurte GA, Langston JW, Delanney LE, Irwin I, Peroutka SJ, Forno LS. 1986. Fate of nigrostriatal neurons in young mature mice given 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a neurochemical and morphological reassessment. Brain Res 376:117-124.
42. Saitoh T, Niijima K, Mizuno Y. 1987. Long-term effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal dopamine content in young and mature mice. J Neurol Sci 77:229-235.
43. Sasaki S, Iwata M. 1996. Ultrastructural study of synapses in the anterior horn neurons of patients with amyotrophic lateral sclerosis. Neurosci Lett 204:53-56.
44. Seniuk NA, Tatton WG, Greenwood CE. 1990. Dose-dependent destruction of the coeruleus - cortical and nigral striatal projections by MPTP. Brain Res 527:7-20.
45. Singer TP, Ramsay RR. 1990. Mechanism of the neurotoxidty of MPTP. An update. FEBS Lett 274:1-8.
46. Snyder GL, Keller RW Jr, Zigmond MJ. 1990. Dopamine efflux from striatal slices after intracerebral 6-hydroxydopamine: evidence for compensatory hyperactivity of residual terminals. J Pharmacol Exp Therapeutics 253:867-876.
47. Sonsalla PK, Heikkila RE. 1986. The influence of dose and dosing interval on MPTP-mduced dopaminergic neurotoxicity in mice. Eur J Pharmacol 129:339-345.
48. Sundström E, Fredriksson A, Archer T. 1990. Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model tor Parkinson's disease. Brain Res 528:181-188.
49. Sundström E, Strömberg I, Tsutsumi T, Olson L, Jonsson G. 1987. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL mice. Comparison with three other strains of mice. Brain Res 405:26-38.
50. Sundström E, Luthman J, Goldstein M, Jonsson G. 1988. Time course of MPTP-induced degeneration of the nigrostriatal dopamine system. Brain Res Bull 21:257-264.
51. Tanaka J, Nakamura H, Honda S, Takada K, Kato S. 1988. Neuropathological study on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine of the crab-eating monkey. Acta Neuropathol 75:370-376.
52. Tetrud JW, Langston JW. 1989. MPTP-induced parkinsonism as a model for Parkinson's disease. Acta Neurol Scand 126:35-40.
53. Wong JYF, Liberatore GT, Donnan GA, Howells DW. 1997. Expression of brain-derived neurotrophic factor and TrkB neurotrophin receptors after striatal injury in the mouse. Exp Neurol 148:83-91.